Page last updated: 2024-10-24

candesartan cilexetil and Cholestasis, Intrahepatic

candesartan cilexetil has been researched along with Cholestasis, Intrahepatic in 1 studies

candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects

Cholestasis, Intrahepatic: Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).

Research Excerpts

ExcerptRelevanceReference
" To our knowledge, this is the first description of severe hepatotoxicity associated with ductopenia caused by an adverse reaction to candesartan cilexetil."1.32Candesartan cilexetil-induced severe hepatotoxicity. ( Accetta, MG; Basile, G; Ferrara, T; Gangemi, S; Nicita-Mauro, V; Villari, D, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basile, G1
Villari, D1
Gangemi, S1
Ferrara, T1
Accetta, MG1
Nicita-Mauro, V1

Other Studies

1 other study available for candesartan cilexetil and Cholestasis, Intrahepatic

ArticleYear
Candesartan cilexetil-induced severe hepatotoxicity.
    Journal of clinical gastroenterology, 2003, Volume: 36, Issue:3

    Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cholestasis, Intrahepatic; Female; Huma

2003